Firebrick announces new product: Nasodine® Throat Spray

  30 Oct 2025

Firebrick Pharma (ASX:FRE) is pleased to announce that it has commenced manufacture of Nasodine® Throat Spray for export in November 2025, which will be the first new product in the Nasodine range since Nasodine Nasal Spray, which was launched in Singapore in 2024. Nasodine Throat Spray is a 1.0% povidone-iodine formulation for treatment of sore…

Read More